These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6090166)

  • 1. Increase in [3H]nitrendipine binding sites in the brain in morphine-tolerant mice.
    Ramkumar V; El-Fakahany EE
    Eur J Pharmacol; 1984 Jul; 102(2):371-2. PubMed ID: 6090166
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations in L-type calcium channels in the brain and spinal cord of acutely treated and morphine-tolerant mice.
    Bernstein MA; Welch SP
    Brain Res; 1995 Oct; 696(1-2):83-8. PubMed ID: 8574689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical dihydropyridine binding sites and a behavioral syndrome in morphine-abstinent rats.
    Antkiewicz-Michaluk L; Michaluk J; Romańska I; Vetulani J
    Eur J Pharmacol; 1990 May; 180(1):129-35. PubMed ID: 2163863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.
    Bolger GT; Marcus KA; Daly JW; Skolnick P
    J Pharmacol Exp Ther; 1987 Mar; 240(3):922-30. PubMed ID: 3031279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of a fraction from brain that inhibits 1,4-[3H]dihydropyridine binding and L-type calcium channel current.
    Janis RA; Shrikhande AV; Johnson DE; McCarthy RT; Howard AD; Greguski R; Scriabine A
    FEBS Lett; 1988 Nov; 239(2):233-6. PubMed ID: 2846356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prolonged administration of clonidine on [3H]PN 200-110 and [125I]omega-conotoxin binding in mouse brain.
    Suematsu M; Ohnishi T; Shinno E; Maeda S; Matsumoto K; Sakuda M; Saito K
    Neurosci Lett; 1993 Dec; 163(2):193-6. PubMed ID: 8309631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebroventricular treatment of mice with pertussis toxin induces hyperalgesia and enhances 3H-nitrendipine binding to synaptic membranes: similarity with morphine tolerance.
    Ohnishi T; Saito K; Maeda S; Matsumoto K; Sakuda M; Inoki R
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):123-7. PubMed ID: 2107404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of 1,4, dihydropyridine calcium channel binding sites in the human prostate.
    Rosenthal E; Shapiro E; Lepor H
    J Urol; 1990 Dec; 144(6):1539-42. PubMed ID: 1700163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of calcium-channel receptors in intact animals.
    Roeske WR; Lee HR; Yamamura HI; Schoemaker H
    Adv Myocardiol; 1985; 6():71-82. PubMed ID: 2986265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central neurochemical effects of dihydropyridine calcium antagonists.
    Huguet F
    Fundam Clin Pharmacol; 1989; 3 Suppl():31s-46s. PubMed ID: 2559012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible binding of [3H]beta-funaltrexamine to brain slices of morphine-tolerant and -dependent mice.
    Takahashi M; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1988 May; 149(3):205-12. PubMed ID: 3409950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of calcium antagonist receptors in highly purified porcine cardiac sarcolemma.
    Haase H; Wallukat G; Vetter R; Will H
    Biomed Biochim Acta; 1987; 46(8-9):S363-9. PubMed ID: 2829862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium.
    Rasmussen RP; Minobe W; Bristow MR
    Biochem Pharmacol; 1990 Feb; 39(4):691-6. PubMed ID: 2154992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tricyclic antidepressants and calcium channel blockers: interactions at the (-)-desmethoxyverapamil binding site and the serotonin transporter.
    Rehavi M; Carmi R; Weizman A
    Eur J Pharmacol; 1988 Oct; 155(1-2):1-9. PubMed ID: 2854066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of receptor sites for [3H]nitrendipine in chick hearts and physiological relation to the slow Ca2+ channel and to excitation-contraction coupling.
    Renaud JF; Kazazoglou T; Schmid A; Romey G; Lazdunski M
    Eur J Biochem; 1984 Mar; 139(3):673-81. PubMed ID: 6321185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor binding properties of the new calcium antagonist benidipine hydrochloride.
    Ishii A; Nishida K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1677-80. PubMed ID: 2851301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]diltiazem binding to calcium channel antagonists recognition sites in rat cerebral cortex.
    Schoemaker H; Langer SZ
    Eur J Pharmacol; 1985 May; 111(2):273-7. PubMed ID: 2410283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hypo- and hyperthyroidism on binding of [3H]-nitrendipine to myocardial and brain membranes.
    Kosinski C; Gross G; Hanft G
    Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):128S-130S. PubMed ID: 2176516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydropyridine and peripheral type benzodiazepine binding sites: subcellular distribution and molecular size determination.
    Doble A; Benavides J; Ferris O; Bertrand P; Menager J; Vaucher N; Burgevin MC; Uzan A; Gueremy C; Le Fur G
    Eur J Pharmacol; 1985 Dec; 119(3):153-67. PubMed ID: 2419140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies with enantiomers of dihydropyridine ligands suggests that there are multiple binding sites associated with the calcium channel.
    O'Neill SK; Bolger GT; Triggle CR
    Proc West Pharmacol Soc; 1990; 33():235-41. PubMed ID: 1703308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.